Business Description
Asarina Pharma AB
ISIN : SE0011641794
Share Class Description:
FRA:APS: Ordinary SharesCompare
Compare
Traded in other countries / regions
ASAP.SwedenAPS.GermanyASRPF.USA IPO Date
2020-08-03Description
Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.69 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 44.7 | |||||
| 3-Year EPS without NRI Growth Rate | 43.1 | |||||
| 3-Year FCF Growth Rate | 48.3 | |||||
| 3-Year Book Growth Rate | -53.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.36 | |||||
| 9-Day RSI | 56.97 | |||||
| 14-Day RSI | 53.11 | |||||
| 6-1 Month Momentum % | 65.53 | |||||
| 12-1 Month Momentum % | -6.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.77 | |||||
| Quick Ratio | 2.77 | |||||
| Cash Ratio | 1.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.1 | |||||
| Shareholder Yield % | -28.81 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -62.45 | |||||
| ROA % | -53.48 | |||||
| ROIC % | -185.88 | |||||
| ROC (Joel Greenblatt) % | -264.41 | |||||
| ROCE % | -59.6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.76 | |||||
| Price-to-Tangible-Book | 3.41 | |||||
| EV-to-EBIT | -2.15 | |||||
| EV-to-EBITDA | -2.22 | |||||
| EV-to-FCF | -1.54 | |||||
| Price-to-Net-Current-Asset-Value | 6.82 | |||||
| Price-to-Net-Cash | 6.82 | |||||
| Earnings Yield (Greenblatt) % | -46.41 | |||||
| FCF Yield % | -47.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Asarina Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.042 | ||
| Beta | 1 | ||
| Volatility % | 91.96 | ||
| 14-Day RSI | 53.11 | ||
| 14-Day ATR (€) | 0.006276 | ||
| 20-Day SMA (€) | 0.06483 | ||
| 12-1 Month Momentum % | -6.32 | ||
| 52-Week Range (€) | 0.0392 - 0.0976 | ||
| Shares Outstanding (Mil) | 22.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Asarina Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Asarina Pharma AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Asarina Pharma AB Frequently Asked Questions
What is Asarina Pharma AB(FRA:APS)'s stock price today?
The current price of FRA:APS is €0.07. The 52 week high of FRA:APS is €0.10 and 52 week low is €0.04.
When is next earnings date of Asarina Pharma AB(FRA:APS)?
The next earnings date of Asarina Pharma AB(FRA:APS) is 2024-08-23 Est..
Does Asarina Pharma AB(FRA:APS) pay dividends? If so, how much?
Asarina Pharma AB(FRA:APS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers